The move by the US government could lead to 200 million BioNTech/Pfizer doses being sent worldwide this year, followed by another 300 million across the first half of2022, according to the individuals familiar with the plan.
The administration of President Joe Biden is buying 500 million doses of the Pfizer-BioNTech Covid-19 vaccine to distribute among other countries, United States media reported Wednesday citing people familiar with the matter.
White House COVID-19 adviser Andy Slavitt, who is stepping down Wednesday from his role, tweeted that it was "HUGE NEWS" before deleting the link.More news: Biden withdraws Trump-era executive order that attempted to ban TikTok, WeChat
Overall, the White House has announced plans to share 80 million doses globally by the end of June, most through Covax.
The US is to distribute half a billion shots of the Pfizer vaccine to 100 other countries.
The administration is also using the USA vaccine supply as a tool to counter Chinese and Russian vaccine diplomacy.More news: Biden Declares US Will Donate 80 Million Vaccine Doses
The U.S. president told reporters before boarding Air Force One for Britain that he had a global vaccine strategy and would be announcing it but did not offer details.
Pfizer Inc said on Tuesday it will start a large study to test its COVID-19 vaccine in children below 12 and selected a dosing regime for the trial. Sinopharm has been approved by the World Health Organisation. But many in his own administration acknowledge that the restrictions were not the driving cause of the global vaccine shortage, which has more to do with limited manufacturing capacity and shortages of delicate raw materials. These groups are more likely to be exposed to the virus that causes COVID-19 due to their occupations.More news: Pentagon UFO report 'doesn't rule out aliens' - although finds no evidence